Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Gains from Investment Securities: 2011-2023

Historic Gains from Investment Securities for Sonoma Pharmaceuticals (SNOA) over the last 9 years, with Mar 2023 value amounting to $1,000.

  • Sonoma Pharmaceuticals' Gains from Investment Securities rose 12.41% to $163,000 in Q1 2013 from the same period last year, while for Mar 2013 it was $624,000, marking a year-over-year increase of 39.29%. This contributed to the annual value of $1,000 for FY2023, which is 99.87% down from last year.
  • As of FY2023, Sonoma Pharmaceuticals' Gains from Investment Securities stood at $1,000, which was down 99.87% from $767,000 recorded in FY2022.
  • Over the past 5 years, Sonoma Pharmaceuticals' Gains from Investment Securities peaked at $3.6 million during FY2020, and registered a low of $1,000 during FY2023.
  • Moreover, its 3-year median value for Gains from Investment Securities was $767,000 (2022), whereas its average is $569,667.
  • Data for Sonoma Pharmaceuticals' Gains from Investment Securities shows a maximum YoY plummeted of 99.87% (in 2023) over the last 5 years.
  • Sonoma Pharmaceuticals' Gains from Investment Securities (Yearly) stood at $3.6 million in 2020, then plummeted by 73.66% to $941,000 in 2021, then decreased by 18.49% to $767,000 in 2022, then plummeted by 99.87% to $1,000 in 2023.